CA Patent

CA2761674C — Treatment of klebsiella pneumoniae infections with antibacterial aminoglycoside compounds

Assigned to Cipla USA Inc · Expires 2016-11-29 · 9y expired

What this patent protects

A method for treating a Klebsiella pneumonia infection in a mammal in need thereof is disclosed, the method comprising administering to the mammal an effective amount of an antibacterial aminoglycoside compound.

USPTO Abstract

A method for treating a Klebsiella pneumonia infection in a mammal in need thereof is disclosed, the method comprising administering to the mammal an effective amount of an antibacterial aminoglycoside compound.

Drugs covered by this patent

Patent Metadata

Patent number
CA2761674C
Jurisdiction
CA
Classification
—
Expires
2016-11-29
Drug substance claim
No
Drug product claim
No
Assignee
Cipla USA Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.